Schering-Plough
SGP
#544
Rank
S$58.55 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: S$2.59 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of S$2.59 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008S$2.59 B
2006S$1.87 B198.39%
2005S$0.63 B-395.83%
2004-S$0.22 Billion265.22%
2003-S$58.32 Million-102.01%
2002S$2.90 B3.62%
2001S$2.80 B-5.39%
2000S$2.96 B
1998S$2.44 B22.34%
1997S$1.99 B38.9%
1996S$1.43 B